Ursprung des Netzwerks ersten Grades von Marie Bengtson
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 29 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marie Bengtson
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Uppsala | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
Stockholm School of Economics | College/University | Masters Business Admin Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Investor Relations Contact | |
University of Gothenburg | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Biotechnology | Founder Chief Executive Officer | |
INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Founder | |
University of Lund | College/University | Undergraduate Degree Graduate Degree | |
MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
University of Stockholm | College/University | Undergraduate Degree Masters Business Admin | |
VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director of Finance/CFO General Counsel | |
SPAGO NANOMEDICAL AB | Biotechnology | Director/Board Member Director/Board Member | |
The Swedish-American Chamber of Commerce, Inc.
The Swedish-American Chamber of Commerce, Inc. Miscellaneous Commercial ServicesCommercial Services The Swedish-American Chamber of Commerce, Inc. is a business organization that provides contacts, partners, and business services to help businesses succeed in the United States. The non-profit company is based in New York, NY, with its office located at 900 3rd Avenue, 29th floor. The chamber offers memberships, marketing opportunities, and events and programming, including the largest transatlantic meet up for female leaders, entrepreneurs, and investors. With over 70 events and three large conferences arranged every year, the chamber's calendar most likely includes the right events for all business needs. | Miscellaneous Commercial Services | Director/Board Member | |
Université Catholique de Louvain | College/University | Graduate Degree | |
Venaticus Capital AB | Director/Board Member | ||
Mahshid Advisors AB | Director/Board Member | ||
FLERIE INVEST AB | Pharmaceuticals: Major | Director/Board Member | |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Avidicare AB
Avidicare AB Medical DistributorsDistribution Services Avidicare AB operates as a medical device company. It specializes in the management of airborne bacteria and virus pollution at hospitals. The firm provides Opragon, a ventilation system for reduction of airborne bacterial contamination in various hospital environments primarily for infection sensitive surgery. The company offers Opragon for preparation rooms, operating theaters, and hybrid rooms; and air curtains and external air showers. Avidicare was founded in 2010 and is headquartered in Lund, Sweden. | Medical Distributors | Director/Board Member | |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member | |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Comptroller/Controller/Auditor | |
Pareto Securities AB
Pareto Securities AB Investment Banks/BrokersFinance Pareto Securities AB is the Swedish brokerage subsidiary of Pareto Securities AS, itself a subsidiary of Pareto AS in Norway. Headquartered in Stockholm, the firm provides full spectrum of brokerage services specifically tailored for both retail and institutional investors. They has expertise in Nordic capital markets and a strong international presence within the oil, offshore, shipping and natural resources sectors. | Investment Banks/Brokers | Analyst-Equity | |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
CODEMILL AB | Packaged Software | Director/Board Member | |
STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Chief Executive Officer | |
Stayble AB | Director/Board Member | ||
Kinnman Solutions AB | Chairman | ||
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
ABLIVA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Danske Bank A/S (Sweden) | Investment Banks/Brokers | Analyst-Equity | |
ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member | |
Swedish Association For Nuclear Medicine | Chairman | ||
Swedish Oncology Association | Chairman | ||
Index Invest International AB
Index Invest International AB Financial ConglomeratesFinance Index Invest International AB provides real estate and equity investment services. Its investment portfolio includes companies in real estate and energy sectors. The company was founded by Bjarne Borg and Fredrik Alama in 1998 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member |
Statistik
International
Schweden | 42 |
Vereinigte Staaten | 4 |
Belgien | 3 |
Vereinigtes Königreich | 2 |
Dänemark | 2 |
Sektoral
Health Technology | 22 |
Consumer Services | 8 |
Finance | 8 |
Commercial Services | 7 |
Distribution Services | 2 |
Operativ
Director/Board Member | 85 |
Corporate Officer/Principal | 36 |
Independent Dir/Board Member | 27 |
Director of Finance/CFO | 20 |
Chief Executive Officer | 19 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Alf Gunnar Martin Nicklasson | 31 |
Lena Elisabeth Svanberg | 16 |
Johan Stuart | 16 |
Mats Blom | 15 |
Peder Sven Walberg | 15 |
Erik Kinnman | 14 |
Yilmaz Mahshid | 12 |
Thomas Lönngren | 11 |
Sten Nilsson | 11 |
Jacques Näsström | 10 |
Marie Ekstrom Tragardh | 10 |
Gunilla Christina Osswald | 9 |
Malin Nittve | 8 |
Karl Hård | 7 |
Michaela Johansson Gertz | 7 |
- Börse
- Insiders
- Marie Bengtson
- Unternehmensverbindungen